Off-the-Shelf vs Custom Korean ODM Formulas: When Market-Tested Wins for Indie Founders (2026)

Every indie K-beauty founder eventually stands at this fork. Do you take a Korean ODM's stock formula and rebrand it, or do you pay to develop a proprietary version? The answer shapes your launch date, your unit cost, your regulatory paperwork, and how defensible your brand looks to buyers.

This guide breaks down the two routes on the same axes so you can decide with numbers rather than instinct. All specifics point to public MFDS, FDA, and industry sources.

What Is an Off-the-Shelf Korean ODM Formula?

An off-the-shelf Korean ODM formula is a fully formulated product base the manufacturer has already developed, stabilized, and often notified with MFDS. The ODM licenses it to multiple brands, who mostly differentiate through packaging, fragrance, and marketing.

Korean ODMs like Cosmax and Kolmar publicly disclose broad off-the-shelf catalogues in their annual reports and investor decks. Kolmar Korea's R&D disclosure notes that a large share of production runs against pre-developed formulation platforms rather than net-new formulas. That share reflects the economics of the category: developing and testing a new base is expensive, and reusing a proven one lowers unit cost for everyone.

For an indie founder, the practical marker of "off-the-shelf" is this: the ODM's account manager sends you a spec sheet, a completed stability report, and an existing MFDS report number within days of your first call. Custom development starts with a blank brief.

How Custom Development Actually Differs From Stock Formulas

Custom development is the process of building a formula from scratch to match a specific brief. The ODM's formulation team drafts multiple prototypes, cycles them through in-house stability and safety testing, then submits the final version for MFDS notification under your product record.

Custom formulas require several dedicated steps that stock formulas skip:

The timeline ranges above track figures reported in Grand View Research's Korea cosmetics market analysis and industry statements from Cosmoprof Asia panels covering ODM lead times. Your exact numbers depend on the ODM's factory schedule and your brief complexity.

Which Route Costs Less Once You Include Testing?

Off-the-shelf costs less on almost every axis for early runs. The formula, stability data, and MFDS record are sunk costs the ODM already amortized across other brands. You pay a bulk unit price plus a modest packaging and labelling markup.

Custom development adds three distinct cost buckets:

1. Formulation labour for R&D time drafting prototypes.
2. Testing: fresh stability, challenge, and safety substantiation. Guidance from MFDS and the ISO 11930 protocol apply.
3. Regulatory filing: a fresh MFDS notification record and, if you export to the US, matching product listing under FDA MOCRA.

The unit price of a custom serum is typically higher than a comparable off-the-shelf serum at the same MOQ because the ODM must recover development spend. If your first PO is small, that recovery is concentrated in your bill. Once you cross a volume where the amortization spreads thinner, custom pricing can approach stock. For most first launches, that break-even sits well above the founder's opening MOQ.

For a full breakdown of what sits inside a Korean ODM's quote line by line, read our line-by-line quote guide.

Regulatory Realities Under Both Routes

Regulatory obligations do not disappear when you pick off-the-shelf. Every finished cosmetic sold in Korea still needs an MFDS notification tied to a responsible party, and every finished cosmetic sold in the US still needs product listing per FDA MOCRA guidance.

The mechanical difference is who does the paperwork and how much of it is fresh.

• Off-the-shelf: The ODM has already notified the formula with MFDS. You typically piggyback under the same product record, updating labelling, PIF ownership, and responsible party. For MOCRA, you file a new product listing pointing to the same facility. Turnaround is fast.
• Custom: A new MFDS notification is required because the ingredient composition differs. Functional claim products such as whitening, anti-wrinkle, and sunscreen trigger MFDS functional cosmetics review, which typically takes months and requires supporting efficacy data. For MOCRA, you file the new product listing with fresh safety substantiation records.

For deeper coverage of the MFDS to FDA handoff on export, see our US market launch playbook.

When Should Indie Founders Pick Off-the-Shelf?

Pick off-the-shelf when speed, MOQ, and cash preservation matter more than deep differentiation on the formula itself. This is the default for most first launches with a modest opening inventory budget.

The scenarios that favour stock formulas:

• First SKU: You want to test brand, packaging, and retail placement before spending on formulation research.
• Small MOQ: Your first PO is under 3,000 units and you cannot spread custom development cost thin enough.
• Standardized category: Cleansers, toners, moisturizers, and basic essences all have deep stock catalogues. The best market-tested versions often outperform custom drafts on stability.
• Buyer-driven launch: A retailer commitment forces a tight ship window (under 12 weeks).
• Brand promise sits outside the formula: Your differentiator is design, ritual, storytelling, or clinical partnership rather than a proprietary active.

If any two of these apply, off-the-shelf is almost certainly the better bet. For a broader view on category selection when launching, our launch guide covers the full sequencing.

The Case for Custom Development

Custom formulas are worth the timeline and cost when your brand story is inseparable from a specific formulation choice.

Three founder profiles typically justify custom:

• Clinical claim brand: You need a specific active concentration (for example, 3% niacinamide plus 0.5% retinal in a stabilized system) that no ODM stock formula matches. Custom lets you dial the exact ratio for a claim you can substantiate.
• Category disruptor: Your positioning depends on an unusual texture, delivery system, or ingredient combination that stock catalogues do not carry. Peptide-plus-PDRN encapsulation is a current example featured in WWD Beauty coverage of 2026 launches.
• Retail exclusivity: A retailer wants a formula that competitors on the same shelf cannot ship. Custom locks it under your product record.

Custom pays off when the formula IS the product. If the formula is a vehicle for other differentiation, custom is usually over-engineering.

Frequently Asked Questions

Can you switch from off-the-shelf to custom later?

Yes. Most founders start with a stock formula for their opening SKUs and commission custom development for hero products once repeat orders justify the spend. The ODM keeps your brand file open and typically references your existing MFDS record structure.

Do off-the-shelf formulas mean lower quality?

No. Stock formulas from top Korean ODMs often go through more real-world stability cycles than a custom formula built in a single development sprint. The MFDS notification database lists tens of thousands of stock formulations from major ODMs with full compliance dossiers on file.

Does off-the-shelf hurt brand story?

Not if handled openly. Many indie brands built around packaging, ritual, or founder narrative use stock formulas without disclosing it publicly, which is legal but risky. A cleaner path is to be transparent that your formulation is licensed from a leading Korean ODM and to focus brand story on why you selected that specific base.

Can two brands share the same off-the-shelf formula?

Yes, and this is common. Korean ODMs typically license the same base to multiple brands, sometimes with minor variations in fragrance, colour, or concentration. Buyers occasionally notice on Reddit or beauty forums. If exclusivity matters to you, ask your ODM for a formula lock clause in writing.

What documents should I request on either route?

Request the full ingredient breakdown with CAS numbers, an MFDS notification number, stability data covering at least three temperature conditions, a PIF template for EU export, and a challenge test report under ISO 11930. Both routes should hand these over before your first PO.

By Liz Song, K-beauty sourcing consultant | 7+ years bridging Korean ODMs and US indie brands. Reviewed for accuracy by ALTA MEET's formulation consulting team.